Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

ALCOHOL AND ALCOHOLISM is a prominent peer-reviewed journal published by Oxford University Press that focuses on a range of topics within the fields of medicine, psychiatry, and toxicology. With an ISSN of 0735-0414 and an E-ISSN of 1464-3502, this journal has carved out a significant niche in the academic landscape since its inception in 1965 and is set to continue its critical role until 2024. Renowned for its rigorous research and scholarly contributions, it holds a respectable Q2 category ranking in 2023 across multiple domains, including Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology. The journal's Scopus rankings further reflect its impact, with commendable percentiles such as the 70th for Medicine (miscellaneous) and the 62nd for Psychiatry and Mental Health. While access is not open, the journal aims to advance knowledge and understanding of alcohol-related issues, making it an indispensable resource for researchers, health professionals, and students interested in the complexities of alcohol consumption and its effects on health and society.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

Cultura y Droga is a prominent journal dedicated to the interdisciplinary study of culture and drug use, published by UNIV CALDAS in Colombia. With its Open Access policy implemented since 2015, this journal strives to make significant research accessible to a global audience, fostering dialogue and innovation in the field. Although specific metrics such as HIndex and Scopus ranks are not provided, the journal is committed to publishing high-quality, peer-reviewed articles that explore the sociocultural dimensions of drug consumption and its implications on public health, policy, and society at large. Researchers, professionals, and students will find this journal an essential resource for advancing their understanding and contributing to critical discussions surrounding drug culture.

Journal of Smoking Cessation, published by HINDAWI LTD, serves as a pivotal platform for research and discourse in the field of smoking cessation and related psychology. With an electronic ISSN of 1834-2612, this open-access journal has been disseminating valuable knowledge since 2021, ensuring that researchers, healthcare professionals, and students have unrestricted access to cutting-edge studies and findings. Based in Australia with an international reach, it engages with a diverse audience committed to understanding the complexities of addiction and mental health, notably ranking in the Q3 category of Psychiatry and Mental Health in 2023. Despite a modest Scopus rank (#376 out of 567), the journal continues to contribute significantly to the literature, providing evidence-based insights and practical solutions for smoking cessation interventions. The converged years from 2006 to 2023 reflect a substantial trajectory of scholarship, making it an essential resource for those dedicated to reducing the prevalence of smoking through innovative research and collaboration.

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

Addicta - The Turkish Journal on Addictions, published by the esteemed Turkish Green Crescent Society, is an open access journal dedicated to advancing the understanding of addictions and their implications on mental health. Since its inception in 2019, this journal has become a significant platform for interdisciplinary research, focusing on the biological, psychological, and sociocultural aspects of addiction. With a focus on both empirical studies and theoretical discussions, Addicta seeks to foster a greater understanding of addiction as a complex phenomenon, facilitating knowledge sharing among researchers, practitioners, and policymakers. The journal has achieved notable rankings, residing in the Q4 category in Biological Psychiatry and Psychiatry and Mental Health, and Q3 in miscellaneous Psychology, marking its growing impact in the field. Accessing its content is completely free, making important research accessible to a broader audience. Based in Turkey, Addicta provides a vital resource for those interested in the nuances of addiction research, promoting innovative solutions and fostering collaboration across disciplines.